My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 571

    1.

    Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.

    Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, Cassader M.

    Diabetes Care. 2008 Mar;31(3):562-8. Epub 2007 Dec 4.PMID: 18056890 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.

    Musso G, Gambino R, De Michieli F, Biroli G, Premoli A, Pagano G, Bo S, Durazzo M, Cassader M.

    Am J Clin Nutr. 2007 Sep;86(3):661-71.PMID: 17823431 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.

    Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, Falezza G.

    Clin Endocrinol (Oxf). 2006 Jun;64(6):679-83.PMID: 16712671 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

    Wong VW, Hui AY, Tsang SW, Chan JL, Tse AM, Chan KF, So WY, Cheng AY, Ng WF, Wong GL, Sung JJ, Chan HL.

    Clin Gastroenterol Hepatol. 2006 Sep;4(9):1154-61. Epub 2006 Aug 14.PMID: 16904946 [PubMed - indexed for MEDLINE]Related articles

    5.

    Adipokines, insulin resistance, and coronary artery calcification.

    Qasim A, Mehta NN, Tadesse MG, Wolfe ML, Rhodes T, Girman C, Reilly MP.

    J Am Coll Cardiol. 2008 Jul 15;52(3):231-6.PMID: 18617073 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.

    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.

    Diabetes Care. 2007 Jan;30(1):113-9. Erratum in: Diabetes Care. 2007 Feb;30(2):455. PMID: 17192343 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.

    Kashyap SR, Diab DL, Baker AR, Yerian L, Bajaj H, Gray-McGuire C, Schauer PR, Gupta M, Feldstein AE, Hazen SL, Stein CM.

    Obesity (Silver Spring). 2009 Sep;17(9):1696-701. Epub 2009 Apr 9.PMID: 19360015 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant.

    Shin MJ, Lee JH, Jang Y, Park E, Oh J, Chung JH, Chung N.

    Metabolism. 2006 Jul;55(7):918-22.PMID: 16784964 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cardiometabolic risk among African American women: a pilot study.

    Appel SJ, Oster RA, Floyd NA, Ovalle F.

    J Cardiovasc Nurs. 2009 Mar-Apr;24(2):140-50.PMID: 19242280 [PubMed - indexed for MEDLINE]Related articles

    10.

    Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects: response to Musso et al.

    Sookoian S, Burgueño AL, Castaño G, Pirola CJ.

    Diabetes Care. 2008 May;31(5):e42; author reply e43. No abstract available. PMID: 18445722 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.

    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.

    Int J Obes (Lond). 2007 Feb;31(2):213-20. Epub 2006 Jun 6.PMID: 16755284 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease.

    Tsai CH, Li TC, Lin CC.

    South Med J. 2008 Sep;101(9):900-5.PMID: 18708987 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.

    Lonardo A, Ballestri S, Adinolfi LE, Violi E, Carulli L, Lombardini S, Scaglioni F, Ricchi M, Ruggiero G, Loria P.

    Can J Gastroenterol. 2009 Apr;23(4):273-8.PMID: 19373421 [PubMed - indexed for MEDLINE]Related articles

    14.

    Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.

    Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G.

    Diabetes Care. 2006 Jun;29(6):1325-30.PMID: 16732016 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

    Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504. Epub 2005 Mar 29.PMID: 15797948 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

    Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J.

    Hepatology. 2004 Jul;40(1):46-54.PMID: 15239085 [PubMed - indexed for MEDLINE]Related articles

    17.

    Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.

    Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PW, Meigs JB.

    J Clin Endocrinol Metab. 2008 Aug;93(8):3165-72. Epub 2008 May 20.PMID: 18492747 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

    Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS.

    Arch Intern Med. 2004 Oct 25;164(19):2169-75.PMID: 15505132 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

    Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall'Aglio E, Dalle Grave R, Morpurgo PS, Tomasi F, Vitacolonna E.

    J Endocrinol Invest. 2005 Apr;28(4):333-9.PMID: 15966506 [PubMed - indexed for MEDLINE]Related articles

    20.

    Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

    Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, Faggian D, Mussap M, Plebani M, Avellini C, Federspil G, Sechi LA, Vettor R.

    J Clin Endocrinol Metab. 2006 Mar;91(3):1081-6. Epub 2006 Jan 4.PMID: 16394091 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity